Motley Fool Staff

Listener Matt worries that it’s a sign of decline for the warehouse retailer.

Despite a big spike in trading volume, however, the company’s share price is holding steady.

News of the $14.5 billion acquisition was no shock to the market, so the target didn’t pop much.

And its earnings warning dragged the rest of the movie-theater segment with it.

The company is down more than 80% since its 2011 IPO. Why is it still flying solo?

Outsider Dirk Van de Put will take the reins this fall.

The third quarter’s $45 billion in revenue might impress some people, but the amount that flowed down to the bottom line was what had Fools’ attention.

The restaurant chain operator turned in better-than-expected earnings and 4% higher comps.

The behind-the-scenes e-commerce enabler is growing at a remarkable clip -- even though profits have yet to arrive.

Sales beat forecasts too, but its future looks less healthy today. And it’s in the middle of an identity crisis.

Back in February, Target warned investors to expect a decline in comp sales and a sharp drop in EPS this year. But so far, 2017 has been better than expected for the discount retail giant.

After years of going it alone, Sears Holdings has struck a deal to sell its private-brand Kenmore appliances through Amazon.com.

Amazon.com's sales continued to rise at a rapid clip last quarter. However, investors were dismayed by a 51% drop in operating profit.

In the past few years, sales growth has ground to a halt and profitability has plunged at Michael Kors. The company hopes to speed its turnaround with a $1.35 billion deal to buy luxury-shoe brand Jimmy Choo.

The tech industry outsider shares his take on workplace culture, entrepreneurship, and more.

Facebook is already gigantic, but it's far from exhausted all its avenues for big growth in the future.

Facebook reported earnings last week, and all the right numbers seem to be trending up in a big way.

YouTube is one of the world’s biggest social media platforms in the world, and it’s raking in tons of revenue for Alphabet.

What was so bad in Alphabet’s earnings that it sent the giant company down a whole 3% in one day?

Novocure’s revolutionary new electrical-field glioblastoma treatment is giving patients around the world new hope, and the company is just getting started.